After Crossing the Blood-Brain Barrier, How Can Gene Editing Move Beyond a “One Disease, One Case” Model? US Funds Shared Platform for Pediatric Brain Disorders
A 12-party team led by the Broad Institute has received up to $34.5 million in support to combine an intravenously administered brain-delivery vector with base and prime editing, initially testing in two severe pediatric neurological diseases whether manufacturing, regulatory review, and clinical trial frameworks can be shared.